E2F1 transactivates IQGAP3, and IQGAP3 competitively inhibits the interaction between PKCδ and PKCα, resulting in phosphorylation and activation of PKCα and promotion of cell proliferation in HCC cells [29]. Here, PRKCD is linked to hepatocellular carcinoma.